Anti-PD1 immunotherapy in MHC-I dysregulated head and neck cancer promotes metastasis via CD8+ T-cell insufficiency
Signal Transduction and Targeted Therapy - Anti-PD1 immunotherapy in MHC-I dysregulated head and neck cancer promotes metastasis via CD8+ T-cell insufficiency